Author： Frost Paul A A.
Publisher： Maney Publishing
ISSN： 1757-093X
Source： Pharmaceutical Programming, Vol.3, Iss.2, 2010-12, pp. : 57-63
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
An agreement reached with AstraZeneca will allow
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 387, 2002-01 ,pp. :
Access to resources
Recommend
Iressa linked to tumour haemorrhage, warns AstraZeneca
Reactions Weekly, Vol. 1, Iss. 1132, 2006-01 ,pp. :
AstraZeneca's rosuvastatin up against Pfizer's atorvastatin in the US
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 426, 2003-01 ,pp. :
DTC advertising planned for `NuvaRing', changes suggested by AstraZeneca
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 491, 2005-01 ,pp. :